Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.

Literature DB >> 29749395

Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.

Guangwu Guo^1,2,3, Noopur S Raje^4,5, Charles Seifer^1,2,3, Jake Kloeber^1,2,3, Randi Isenhart^1,2,3, Gavin Ha^1,3, Andrew J Yee^4,5, Elizabeth K O'Donnell^4,5, Yu-Tzu Tai^1,4, Paul G Richardson^1,4,6, Giada Bianchi^1,4,6, Jacob P Laubach^1,4,6, Diane Warren^1,4, Erica Gemme⁵, Jordan Voisine^1,2,3, Julia Frede^1,2,3, Antonis Kokkalis^1,2,3, Huiyoung Yun^1,2,3, Valeriya Dimitrova^1,2,3, Tushara Vijaykumar^1,2,3, Matthew Meyerson^1,3,4,7,8, Nikhil C Munshi^1,4,6, Kenneth C Anderson^1,4,6, Birgit Knoechel^2,3,4, Jens G Lohr^9,10,11,12.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2018 PMID： 29749395 PMCID： PMC6160352 DOI： 10.1038/s41375-018-0115-z

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

14 in total

Review 1. Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.

Authors: Brian G M Durie
Journal: Cancer Treat Rev Date: 2010-05 Impact factor: 12.111

2. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Authors: L Rasche; S S Chavan; O W Stephens; P H Patel; R Tytarenko; C Ashby; M Bauer; C Stein; S Deshpande; C Wardell; T Buzder; G Molnar; M Zangari; F van Rhee; S Thanendrarajan; C Schinke; J Epstein; F E Davies; B A Walker; T Meissner; B Barlogie; G J Morgan; N Weinhold
Journal: Nat Commun Date: 2017-08-16 Impact factor: 14.919

Review 3. Treatment for patients with newly diagnosed multiple myeloma in 2015.

Authors: María-Victoria Mateos; Enrique M Ocio; Bruno Paiva; Laura Rosiñol; Joaquín Martínez-López; Joan Bladé; Juan-José Lahuerta; Ramón García-Sanz; Jesús F San Miguel
Journal: Blood Rev Date: 2015-06-12 Impact factor: 8.250

4. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.

Authors: Jan B Egan; Chang-Xin Shi; Waibhav Tembe; Alexis Christoforides; Ahmet Kurdoglu; Shripad Sinari; Sumit Middha; Yan Asmann; Jessica Schmidt; Esteban Braggio; Jonathan J Keats; Rafael Fonseca; P Leif Bergsagel; David W Craig; John D Carpten; A Keith Stewart
Journal: Blood Date: 2012-04-23 Impact factor: 22.113

5. Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.

Authors: Jens G Lohr; Sora Kim; Joshua Gould; Birgit Knoechel; Yotam Drier; Matthew J Cotton; Daniel Gray; Nicole Birrer; Bang Wong; Gavin Ha; Cheng-Zhong Zhang; Guangwu Guo; Matthew Meyerson; Andrew J Yee; Jesse S Boehm; Noopur Raje; Todd R Golub
Journal: Sci Transl Med Date: 2016-11-02 Impact factor: 17.956

6. Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA.

Authors: Anna Oberle; Anna Brandt; Minna Voigtlaender; Benjamin Thiele; Janina Radloff; Anita Schulenkorf; Malik Alawi; Nuray Akyüz; Manuela März; Christopher T Ford; Artus Krohn-Grimberghe; Mascha Binder
Journal: Haematologica Date: 2017-02-09 Impact factor: 9.941

7. Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Authors: Olena Kis; Rayan Kaedbey; Signy Chow; Arnavaz Danesh; Mark Dowar; Tiantian Li; Zhihua Li; Jessica Liu; Mark Mansour; Esther Masih-Khan; Tong Zhang; Scott V Bratman; Amit M Oza; Suzanne Kamel-Reid; Suzanne Trudel; Trevor J Pugh
Journal: Nat Commun Date: 2017-05-11 Impact factor: 14.919

8. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.

Authors: Jens G Lohr; Petar Stojanov; Scott L Carter; Peter Cruz-Gordillo; Michael S Lawrence; Daniel Auclair; Carrie Sougnez; Birgit Knoechel; Joshua Gould; Gordon Saksena; Kristian Cibulskis; Aaron McKenna; Michael A Chapman; Ravid Straussman; Joan Levy; Louise M Perkins; Jonathan J Keats; Steven E Schumacher; Mara Rosenberg; Gad Getz; Todd R Golub
Journal: Cancer Cell Date: 2014-01-13 Impact factor: 31.743

9. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.

Authors: Viktor A Adalsteinsson; Gavin Ha; Samuel S Freeman; Atish D Choudhury; Daniel G Stover; Heather A Parsons; Gregory Gydush; Sarah C Reed; Denisse Rotem; Justin Rhoades; Denis Loginov; Dimitri Livitz; Daniel Rosebrock; Ignaty Leshchiner; Jaegil Kim; Chip Stewart; Mara Rosenberg; Joshua M Francis; Cheng-Zhong Zhang; Ofir Cohen; Coyin Oh; Huiming Ding; Paz Polak; Max Lloyd; Sairah Mahmud; Karla Helvie; Margaret S Merrill; Rebecca A Santiago; Edward P O'Connor; Seong H Jeong; Rachel Leeson; Rachel M Barry; Joseph F Kramkowski; Zhenwei Zhang; Laura Polacek; Jens G Lohr; Molly Schleicher; Emily Lipscomb; Andrea Saltzman; Nelly M Oliver; Lori Marini; Adrienne G Waks; Lauren C Harshman; Sara M Tolaney; Eliezer M Van Allen; Eric P Winer; Nancy U Lin; Mari Nakabayashi; Mary-Ellen Taplin; Cory M Johannessen; Levi A Garraway; Todd R Golub; Jesse S Boehm; Nikhil Wagle; Gad Getz; J Christopher Love; Matthew Meyerson
Journal: Nat Commun Date: 2017-11-06 Impact factor: 14.919

10. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

Authors: Brian A Walker; Eileen M Boyle; Christopher P Wardell; Alex Murison; Dil B Begum; Nasrin M Dahir; Paula Z Proszek; David C Johnson; Martin F Kaiser; Lorenzo Melchor; Lauren I Aronson; Matthew Scales; Charlotte Pawlyn; Fabio Mirabella; John R Jones; Annamaria Brioli; Aneta Mikulasova; David A Cairns; Walter M Gregory; Ana Quartilho; Mark T Drayson; Nigel Russell; Gordon Cook; Graham H Jackson; Xavier Leleu; Faith E Davies; Gareth J Morgan
Journal: J Clin Oncol Date: 2015-08-17 Impact factor: 44.544

22 in total

1. Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.

Authors: Céline Mazzotti; Laure Buisson; Sabrina Maheo; Aurore Perrot; Marie-Lorraine Chretien; Xavier Leleu; Cyrille Hulin; Salomon Manier; Benjamin Hébraud; Murielle Roussel; Laura Do Souto; Michel Attal; Hervé Avet-Loiseau; Jill Corre
Journal: Blood Adv Date: 2018-11-13

Review 2. Tracking myeloma tumor DNA in peripheral blood.

Authors: Johannes M Waldschmidt; Tushara Vijaykumar; Birgit Knoechel; Jens G Lohr
Journal: Best Pract Res Clin Haematol Date: 2020-01-14 Impact factor: 3.020

3. Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow.

Authors: M A Baertsch; R Lutz; M S Raab; N Weinhold; H Goldschmidt
Journal: J Cancer Res Clin Oncol Date: 2019-08-12 Impact factor: 4.553

4. Minimal residual disease in multiple myeloma: why, when, where.

Authors: Andrew J Yee; Noopur Raje
Journal: Hematology Am Soc Hematol Educ Program Date: 2021-12-10

Review 5. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.

Authors: Ankit K Dutta; Jean-Baptiste Alberge; Romanos Sklavenitis-Pistofidis; Elizabeth D Lightbody; Gad Getz; Irene M Ghobrial
Journal: Nat Rev Clin Oncol Date: 2022-01-11 Impact factor: 65.011

Review 6. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.

Authors: Sridurga Mithraprabhu; Maoshan Chen; Ioanna Savvidou; Antonia Reale; Andrew Spencer
Journal: Leukemia Date: 2021-07-14 Impact factor: 11.528

Review 7. Role of Circulating Tumor DNA in Hematological Malignancy.

Authors: Miho Ogawa; Kazuaki Yokoyama; Seiya Imoto; Arinobu Tojo
Journal: Cancers (Basel) Date: 2021-04-25 Impact factor: 6.639

8. Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial.

Authors: James Croft; Sidra Ellis; Amy L Sherborne; Kim Sharp; Amy Price; Matthew W Jenner; Mark T Drayson; Roger G Owen; Sally Chown; Jindriska Lindsay; Kamaraj Karunanithi; Hannah Hunter; Walter M Gregory; Faith E Davies; Gareth J Morgan; Gordon Cook; Lilit Atanesyan; Suvi Savola; David A Cairns; Graham Jackson; Richard S Houlston; Martin F Kaiser
Journal: Leukemia Date: 2020-12-01 Impact factor: 11.528

Review 9. Measurable residual disease in multiple myeloma: ready for clinical practice?

Authors: Leire Burgos; Noemi Puig; Maria-Teresa Cedena; María-Victoria Mateos; Juan José Lahuerta; Bruno Paiva; Jesús F San-Miguel
Journal: J Hematol Oncol Date: 2020-06-22 Impact factor: 17.388

Review 10. Germline Risk Contribution to Genomic Instability in Multiple Myeloma.

Authors: Siegfried Janz; Fenghuang Zhan; Fumou Sun; Yan Cheng; Michael Pisano; Ye Yang; Hartmut Goldschmidt; Parameswaran Hari
Journal: Front Genet Date: 2019-05-08 Impact factor: 4.599